All HCCI Reports
HCCI’s original reports powered by #HCCIdata

Blood cancers represent a range of diseases that can affect blood cells, bone marrow, lymph nodes, and other parts of the lymphatic system. Health care claims data can provide insights into how many people are dealing with blood cancers. Using claims data from people enrolled in Medicaid, employer-sponsored insurance (ESI), and Traditional Medicare, this data brief highlights the percentage of peo...

Previously, HCCI analyzed Ozempic medication use in the ESI population and found that the percentage of patients using Ozempic that had a diabetes diagnosis, the condition Ozempic is clinically indicated to treat, had decreased from 92% in 2018 to 77% 2021. This indicated a growing trend of off-label use of Ozempic. Our findings aligned with reports at the time of off-label use of Ozempic for weig...

Colorectal cancer is the fourth most commonly diagnosed cancer in the U.S. and the second leading cause of cancer death. Recently, a growing number of young people have been diagnosed with colorectal cancer. According to the American College of Surgeons, the incidence rate of early onset colorectal cancer is expected to double by 2030. While these statistics are alarming, colon and rectal cancer a...

Prior HCCI research has shown that women are more likely to use health care services than men. Among people who receive health insurance through their employer, we find that women are, on average, 1.4 times more likely to receive any health care services than men, and this trend has remained consistent over time. As shown in Figure 1, utilization differences vary slightly by service categories. Wo...

The Health Care Cost Institute (HCCI), in collaboration with West Health, conducted an analysis on the use of office-based mental health services among people with employer-sponsored insurance (ESI). We found that use of mental health services has increased from 2018-2022, and that therapy was the most commonly used service. We found an increase in spending on therapy services from 2018-2022 drive...

The Health Care Cost Institute (HCCI), in collaboration with West Health, conducted an analysis on the use of telehealth mental health services among people with employer-sponsored insurance (ESI). We found that telehealth played an outsized role in the delivery of mental health services starting in 2020, with over 40% of mental health visits occurring via telehealth from 2020-2022. Fema...

The International Federation of Health Plans (iFHP) has published its 2024 International Healthcare Cost Comparison Report, marking its latest biennial analysis of global healthcare costs. Compiled in collaboration with the Health Care Cost Institute (HCCI), the report compares costs for inpatient and outpatient treatments, as well as prescription drugs, across nine countries using data from 2022....

Policymakers and clinician consortia have identified low value care, defined as health care services that provide negligible clinical benefit to the patient when provided, as one way to curb excessive and inefficient medical spending. A previous HCCI report found that 18% of people with employer-sponsored insurance in 2019 received at least one low-value service, which corresponded to 2.6% of over...

High and rising health care costs affect individuals, families, and businesses across the country, and they have for decades. Cost forces difficult choices between health care and other needs. The Health Care Cost Institute's mission of using data and analytics to improve the US health care system recognizes that people are at the heart of health care, and we are committed to putting our clai...

Ambulances contribute to urgent lifesaving and life-enhancing medical care, but the unplanned nature of this essential service can lead to high unexpected costs to patients. This HCCI data brief focuses on ground ambulances, which make up 98% of all ambulance trips, and builds upon earlier work that explored 10-year trends in ambulance prices, utilization, spending, and the frequency of out-of-net...

Recent data from the Health Care Cost Institute (HCCI) show that growth in hospitals' commercial inpatient prices was higher in system-affiliated and non-profit hospitals from 2012-2021.  Key Findings: In the backdrop of a wave of hospital mergers, system-affiliated non-profit hospitals account for more than half of short-term general acute care hospitals in the US (from 50.6% in 2012 to 62.5...

Biologic drugs treat a range of diseases such as cancer, diabetes, retinal diseases, Crohn's disease and many other conditions. Despite accounting for use by just 2% of Americans, spending on biologics is a major driver of drug spending in the United States. Biologics often come with a hefty price tag; for example, the most commonly used biologic drug, Humira, can have out-of-pocket costs that run...

The Health Care Cost Institute (HCCI) in collaboration with West Health conducted an analysis of the high prices that employer-based insurance pays hospital outpatient departments for clinical lab tests. We found that insurers are paying, on average, 3 times more for common lab tests such as blood and urine test when billed by hospital outpatient departments compared to independent laboratories. D...

Building on a commitment to health care price transparency that spans more than a decade, the Health Care Cost Institute is excited to introduce HealthPrices.Org (formerly Guroo), a free health care price transparency tool that shows consumers the average prices for health care services in their local metropolitan area. Access to data on prices can help consumers, employers, and other purchasers o...

According to the most recent year of data available, an estimated 42% of adults have obesity and almost 20% of children are diagnosed with obesity. It is well documented that obesity prevalence and associated health care costs continue to rise. The Kaiser Family Foundation has estimated the average annual health spending for people enrolled in commercial insurance diagnosed with obesity ...

HCCI collaborated with the National Kidney Foundation and The DataFace to develop a national and state-level multi-payer dashboard that examines the current state of Chronic Kidney Disease (CKD) in the US and highlights the gaps in CKD-related care. Our interactive tool allows users to examine the rates of CKD testing and diagnosis among people at-risk for CKD. It also highlights CKD quality of ca...

Menopause is clinically defined as the end of a female's menstrual cycle, but for many, this stage of life is marked by uncertainty and confusion. It is a period where information is vague, experience is poorly understood, and it leaves many women feeling isolated as they navigate the complex changes of aging. Each year, nearly two million women enter menopause, yet there is a significant knowledg...

The amount of health care services people use varies widely across the population and can change year to year. People may require a higher amount of care in one year and fewer services the next. Although "high utilizers" are often discussed, there are people who do not use any services throughout the year. Other than being in good physical health, people may not seek care for a variety of reasons ...

The Lower Costs, More Transparency Act (H.R. 5378) currently before Congress aims to increase price transparency in health care and address the high cost of prescription drugs. One of the provisions of the bill would change the way Medicare pays for physician administered drugs. Currently, Medicare pays a higher price for drugs that are administered in a hospital outpatient setting than drugs that...

Technological medical advancements have shifted an array of procedures previously rendered in inpatient hospitals to ambulatory surgical centers (ASCs). For example, same-day procedures (e.g., cataracts surgery) that do not require an overnight hospital stay and musculoskeletal procedures, such as arthroscopy, are commonly performed at ASCs.  Because they operate independently of brick-a...

Cardiac rehabilitation is a program to help patients with heart events recover and return to normal activities. It is recommended following acute heart events and as a component of addressing chronic heart failure. Despite recommendations from federal agencies, advocacy groups, and national health associations and the documented benefits of cardiac rehabilitation, only 20-30% of people who could b...

10 FAQs about Employer-based Health Plans Recent data from the Health Care Cost Institute (HCCI) show that price growth accounted for more than half the change in per person health care spending from 2017 to 2021. Nearly half of people in the US get health insurance through work, either through their own employer or as a dependent. Accordingly, rising health care spending is a big problem for empl...

The CDC defines Severe Maternal Morbidity (SMM) as 'unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health.' These outcomes are largely preventable and are an important indicator of maternal health care quality. The CDC reports that SMM has steadily increased in recent years, and the consequences are wide-ranging, including detrime...

Health care spending continues to grow, and prices are the primary driver. Without addressing high and growing prices, efforts to make care more affordable will not be successful. One way to understand what is going on with prices in employer-sponsored insurance (ESI) is to compare negotiated rates paid in that market to Medicare payments for the same services. New analysis from the Heal...

The World Health Organization reported that, following the COVID-19 pandemic, there was a 25% increase in the prevalence of anxiety and depression worldwide. Mental health crises following months and years of social isolation and other effects of the pandemic have renewed national interest in mental health care access. Understanding how mental health services, including medications used to treat m...